← Eichor
Condition: Germline Mutation Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Germline Mutation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT07019155The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.
Phase N/A · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT05097274Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations
Phase N/A · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT02705846DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Phase N/A · 2 location(s) · National Cancer Institute (NCI) · NCT01247597Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
Phase 2 · 3 location(s) · Okayama University · NCT05485766A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Su
Phase 1 · 1 location(s) · Boryung Pharmaceutical Co., Ltd · NCT07069335Germline Genetic Testing of the TP53 Gene
Phase N/A · 1 location(s) · European Institute of Oncology · NCT07419893Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05769517Early Diagnosis of High-grade Serous Epithelial Ovarian Cancer Through the Analysis of DNA Derived From Pap Test Smear.
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07556562Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation
NA · 23 location(s) · Institut Claudius Regaud · NCT05983991Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes
Phase N/A · 1 location(s) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di · NCT03058588Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.
NA · 5 location(s) · Institut Claudius Regaud · NCT06022016Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT07039552Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Phase N/A · 11 location(s) · University of Kansas Medical Center · NCT02302742Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2
Phase N/A · 1 location(s) · Translational Research Center for Medical Innovation, Kobe, · NCT03296826Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomark
NA · 25 location(s) · Institut Claudius Regaud · NCT05378204Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT03830229Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Phase N/A · 5 location(s) · Boston Children's Hospital · NCT02461446Unveiling the Germline Predisposition to Myeloproliferative Neoplasms
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07204392Natural History Study of CADASIL
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT05072483Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and M
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT04431024PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC
Phase 3 · 1 location(s) · Guangdong Provincial People's Hospital · NCT06533384PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effe
Phase N/A · 3 location(s) · Prostate Cancer Clinical Trials Consortium · NCT04995198Fluzoparib Combined With Camrelizumab for Neoadjuvant Treatment of Embryogenic BRCA Mutation HER2 Negative Breast Cancer
Phase 2 · 1 location(s) · Peking University People's Hospital · NCT05576389A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT01994057Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Phase 1 · 8 location(s) · Senhwa Biosciences, Inc. · NCT04890613Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04090567A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)
NA · 1 location(s) · Vasileios Kalles · NCT07292246Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Phase N/A · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT02280161Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
Phase N/A · 3 location(s) · Sydney Children's Hospitals Network · NCT04903782
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.